Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Schering-Plough asthma drug, oral contraceptive being reviewed by European regulators
Yahoo/AP
Wednesday, August 26, 2009 - 4:49pm
tags:
Schering Plough, asthma, contraceptives, EU, Europe
Boehringer Ingelheim Axes 600-900 Drug Sales Reps
BNET Pharma
Wednesday, August 26, 2009 - 3:44pm
tags:
Boehringer Ingelheim, layoffs
Merck says European Union agrees to review intravenous version of heart drug vernakalant
Yahoo/AP
Wednesday, August 26, 2009 - 3:42pm
tags:
Merck, EU, European, Vernakalant
J&J consolidating management, starting by eliminating new comprehensive care business unit
Yahoo/AP
Wednesday, August 26, 2009 - 10:34am
tags:
JNJ
Human Genome leads biotech stocks north
Marketwatch
Wednesday, August 26, 2009 - 10:22am
tags:
biotech, Human Genome Sciences, GSK, M&A
Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval
Seeking Alpha
Wednesday, August 26, 2009 - 10:21am
tags:
Vion Pharmaceuticals, FDA, Onrigin, AML
Pfizer unveils $214M biotech plant
Fierce Biotech
Wednesday, August 26, 2009 - 10:20am
tags:
Pfizer, Europe, biotech
Bristol-Myers says FDA broadens label for Orencia
Yahoo/AP
Wednesday, August 26, 2009 - 10:18am
tags:
FDA, Bristol-Myers Squibb, Orencia, rheumatoid arthritis
Glaxo Comes To The Defense Of Its alli
CNBC
Wednesday, August 26, 2009 - 10:18am
tags:
GSK, obesity, Alli, diet drugs
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S
PR Newswire
Wednesday, August 26, 2009 - 9:09am
tags:
Endo, Foretesta, partnerships, Prostrakan
Galderma Distributed Bogus PI for Skin Drug, FDA Claims
BNET Pharma
Wednesday, August 26, 2009 - 8:30am
tags:
Galderma, Tri-Luma
Amgen's anemia drug fails in kidney patient study
Yahoo/AP
Wednesday, August 26, 2009 - 8:28am
tags:
Amgen, anemia, Aranesp
European Drug Makers: More Innovative Than U.S. Companies?
WSJ Online
Tuesday, August 25, 2009 - 6:00pm
tags:
innovation, Europe, United States
Glaxo deal talk boosts Human Genome shares
Yahoo/AP
Tuesday, August 25, 2009 - 5:59pm
tags:
GSK, M&A, Human Genome Sciences
Merck Regaining Its Swagger
Investopedia
Tuesday, August 25, 2009 - 5:57pm
tags:
Merck
Short-selling investor turns to drugs in search of next big hit
Times Online, UK
Tuesday, August 25, 2009 - 5:56pm
tags:
short selling, drug stocks
Shire Aims Big in HGT Segment
Yahoo/Zacks.com
Tuesday, August 25, 2009 - 2:08pm
tags:
Shire, HGT, Santaris
Swine Flu Vaccine to Miss Target
Yahoo/Zacks.com
Tuesday, August 25, 2009 - 2:07pm
tags:
swine flu, H1N1, vaccines, GSK, Baxter International, AstraZeneca
Allergan - More Than Skin Deep?
RTT News
Tuesday, August 25, 2009 - 12:23pm
tags:
Allergan
Acorda confirms FDA panel review date for MS drug
Yahoo/AP
Tuesday, August 25, 2009 - 12:21pm
tags:
Acorda Therapeutics, MS, FDA, multiple sclerosis, Fampridine-SR

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.